Expression of epstein‐barr‐virus‐related nuclear antigens and B‐cell markers in lymphomas of SIV‐immunosuppressed monkeys
- 21 October 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (4) , 609-615
- https://doi.org/10.1002/ijc.2910550416
Abstract
Simian-immunodeficiency-virus(SIV)-infected cynomolgus monkeys develop B-cell lymphomas in approximately one third of the cases. We have now studied the expression of cynomolgus-Epstein-Barr-virus(cyno-EBV) nuclear antigens in 13 cyno-EBV-carrying SIVsm-associated monkey lymphomas and established cell lines from 3 of these tumors. Immunoblots of cell lysates were probed with polyspecific and monospecific reagents directed against human EB-virus EBNA1-6, and against the membrane protein LMP1. An EBNA2-cross-reacting protein was demonstrated in 8 lymphoma tissues (8/13) and in the 3 cell lines derived from the tumors. All tumors expressed a polypeptide with 50 to 55 kDa molecular weight, which cross-reacted with some antibodies to EBNA1. Absorption experiments with normal monkey tissue showed that this polypeptide was specific for the cyno-EBV-carrying lymphoma cells. Equivalents of EBNA3-6 and LMP1 could not be detected. Immunophenotypical characterization showed that the monkey lymphomas were similar to human HIV-associated B-cell lymphomas. Malignant B-cell lymphomas in experimentally SIVsm-infected cynomolgus monkeys can be a model for EBV-associated lymphomagenesis in immunodeficiency states. This study was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Society and Erik and Edith Fernström's Foundation for Medical Research. We thank Dr. J. Dillner (Department of Virology, Karolinska Institute) for helpful suggestions, Ms. A. de Santiago de Aguilar, Ms. M. Ekman and Ms. R. Gendelman for skillful technical assistance, and Drs. A. Rickinson and M. Rowe, CRC laboratories, for PE-2 MAb. H. F. was partly supported as a visiting scientist by the European Community Concerted Action “Pathophysiology and immunology of HIV-related diseases”, and E.K. (visiting scientist from Muhimbili Medical Centre, Dar-es-Salaam, Tanzania) was supported by the Swedish Agency for Research Cooperation with Developing Countries (SAREC) and World Laboratory (Project MDC 2).Keywords
This publication has 32 references indexed in Scilit:
- A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome.The Journal of Experimental Medicine, 1992
- Malignant Lymphoma Associated with Human AIDS and with SIV-Induced Immunodeficiency in MacaquesAIDS Research and Human Retroviruses, 1992
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Absence, or low expression, of leukocyte adhesion molecules CDI1 and CD18 on burkjtt lymphoma cellsInternational Journal of Cancer, 1988
- Nuclear DNA-binding Proteins Determined by the Epstein-Barr Virus-related Simian Lymphotropic Herpesviruses H. gorilla, H. pan, H. pongo and H. papioJournal of General Virology, 1987
- Monoclonal Antibodies to the Latent Membrane Protein of Epstein-Barr Virus Reveal Heterogeneity of the Protein and Inducible Expression in Virus-transformed CellsJournal of General Virology, 1987
- Ligation of the CD23, p45 (BLAST‐2, EBVCS) antigen triggers the cell‐cycle progression of activated B lymphocytesEuropean Journal of Immunology, 1986
- Heterogeneity of epstein‐barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in ramos cellsInternational Journal of Cancer, 1978
- Transforming Activity and Antigenicity of an Epstein-Barr-Like Virus from Lymphoblastoid Cell Lines of Baboons with Lymphoid DiseaseIntervirology, 1977
- Properties of a baboon lymphotropic herpesvirus related to Epstein‐Barr virusInternational Journal of Cancer, 1976